General
Preferred name
FORMONONETIN
Synonyms
Biochanin B ()
Flavosil ()
Formononetol ()
Formononetin (Formononetol) ()
Formononetin, Formononetol, Biochanin B, ()
Formononetol, Biochanin B ()
7-hydroxy-4'-methoxyisoflavone ()
Neochanin ()
Myconate ()
NSC-93360 ()
Mycotech ()
P&D ID
PD002254
CAS
485-72-3
Tags
available
drug candidate
nuisance
Drug indication
Discovery agent
Osteoporosis
Drug Status
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 ¦ÌM. Formononetin potently inhibits angiogenesis and tumor growth[1].
PRICE 37
DESCRIPTION Formononetin is an inhibitor of aryl hydrocarbon receptor (EC50 = 0.25µM), estrogen receptor (Kd = 40 nM) and pancreatic lipase. It is a potent FGFR2 inhibitor and has antitumor and antiviral activity. (Enamine Bioactive Compounds)
DESCRIPTION Formononetin (Flavosil) is an O-methylated isoflavone and a phytoestrogen from the root of Astragalus membranaceus. (TargetMol Bioactive Compound Library)
Cell lines
11
Organisms
2
Compound Sets
15
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugMAP
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
JUMP-Target 1 Compound Set
MedChem Express Bioactive Compound Library
Nuisance compounds in cellular assays
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
40
Properties
(calculated by RDKit )
Molecular Weight
268.07
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
3
cLogP
3.17
TPSA
59.67
Fraction CSP3
0.06
Chiral centers
0.0
Largest ring
6.0
QED
0.78
Structural alerts
1
Nonspecific/NOS
Flavonoid
Nuisance compounds
Custom attributes
(extracted from source data)
Target
Apoptosis
FGFR
ADH1C, SLC5A2
ADH1C
MOA
alcohol dehydrogenase inhibitor
Pathway
Protein Tyrosine Kinase/RTK
Angiogenesis
Tyrosine Kinase/Adaptors
Source data